(Q33397004)

English

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Escherichia coli

1 reference

based on heuristic

inferred from title

object named as

Mario Schiffer

11

0 references

object named as

Markus M Lerch

13

0 references

Andreas Greinacher

1

object named as

Andreas Greinacher

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15

object named as

Julia Mayerle

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Sigrun Friesecke

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter Abel

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alexander Dressel

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sylvia Stracke

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael Fiene

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Friedlinde Ernst

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathleen Selleng

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Karin Weissenborn

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bernhard M W Schmidt

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stephan B Felix

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jan T Kielstein

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

2 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

378

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9797

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1166-1173

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombotic Microangiopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of typical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Eculizumab in severe Shiga-toxin-associated HUS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoadsorption (IAS) for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoadsorption as treatment option in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroid insufficiency in acutely ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal aspects of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The temporal profile of the anti-PF4/heparin immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the immune response in heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961253-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)61253-1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33397004&oldid=1784157962"